Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 659


Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.

Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, Wolmark N.

J Natl Cancer Inst. 2006 Nov 15;98(22):1647-54.


Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.

Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, Wickerham DL.

Breast Cancer Res Treat. 2006 Jun;97(3):245-54. Epub 2005 Dec 6.


Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.

Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB 3rd, Macdonald JS, Fuchs CS.

Cancer. 2003 Aug 1;98(3):484-95.


Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.

Smith RE, Colangelo L, Wieand HS, Begovic M, Wolmark N.

J Natl Cancer Inst. 2004 Aug 4;96(15):1128-32.


Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D, O'Connell MJ, Mayer RJ, Cummings B, Willett C, Macdonald JS, Benson AB 3rd, Fuchs CS.

J Clin Oncol. 2004 Feb 15;22(4):648-57.


Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project.

Dignam JJ, Colangelo L, Tian W, Jones J, Smith R, Wickerham DL, Wolmark N.

J Natl Cancer Inst. 1999 Nov 17;91(22):1933-40.


Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma.

Labianca R, Fossati R, Zaniboni A, Torri V, Marsoni S, Nitti D, Boffi L, Scatizzi M, Tardio B, Mastrodonato N, Banducci S, Consani G, Pancera G; ACOI/GIVIO/GISCAD Investigators.

J Natl Cancer Inst. 2004 May 19;96(10):750-8.


Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy.

Sinicrope FA, Foster NR, Yothers G, Benson A, Seitz JF, Labianca R, Goldberg RM, Degramont A, O'Connell MJ, Sargent DJ; Adjuvant Colon Cancer Endpoints (ACCENT) Group.

Cancer. 2013 Apr 15;119(8):1528-36. doi: 10.1002/cncr.27938. Epub 2013 Jan 10.


Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study.

von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR.

Cancer. 2006 Dec 15;107(12):2786-91.


Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

Navarro WH, Loberiza FR Jr, Bajorunaite R, van Besien K, Vose JM, Lazarus HM, Rizzo JD.

Biol Blood Marrow Transplant. 2006 May;12(5):541-51.


Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.

Yothers G, Sargent DJ, Wolmark N, Goldberg RM, O'Connell MJ, Benedetti JK, Saltz LB, Dignam JJ, Blackstock AW; ACCENT Collaborative Group.

J Natl Cancer Inst. 2011 Oct 19;103(20):1498-506. doi: 10.1093/jnci/djr310. Epub 2011 Oct 12.


Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP.

J Natl Cancer Inst. 2003 Oct 1;95(19):1467-76.


Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer.

de Oca J, Azuara D, Sanchez-Santos R, Navarro M, Capella G, Moreno V, Sola A, Hotter G, Biondo S, Osorio A, Martí-Ragué J, Rafecas A.

Int J Colorectal Dis. 2008 Jan;23(1):21-7. Epub 2007 Sep 4.


Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004.

Meulenbeld HJ, van Steenbergen LN, Janssen-Heijnen ML, Lemmens VE, Creemers GJ.

Ann Oncol. 2008 Sep;19(9):1600-4. doi: 10.1093/annonc/mdn176. Epub 2008 May 7.


Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL, Fuchs CS.

J Clin Oncol. 2006 Aug 1;24(22):3535-41. Epub 2006 Jul 5.


Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials.

Sinicrope FA, Foster NR, Yoon HH, Smyrk TC, Kim GP, Allegra CJ, Yothers G, Nikcevich DA, Sargent DJ.

J Clin Oncol. 2012 Feb 1;30(4):406-12. doi: 10.1200/JCO.2011.39.2563. Epub 2011 Dec 27.


Effect of body mass index on chemoradiation outcomes in head and neck cancer.

McRackan TR, Watkins JM, Herrin AE, Garrett-Mayer EM, Sharma AK, Day TA, Gillespie MB.

Laryngoscope. 2008 Jul;118(7):1180-5. doi: 10.1097/MLG.0b013e31816fca5c.


Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer.

Bastarrachea J, Hortobagyi GN, Smith TL, Kau SW, Buzdar AU.

Ann Intern Med. 1994 Jan 1;120(1):18-25.


The obesity paradox: body mass index and outcomes in patients with heart failure.

Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM.

Arch Intern Med. 2005 Jan 10;165(1):55-61. Erratum in: Arch Intern Med. 2008 Mar 24;168(6):567.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk